Cerenion awarded third patent on its C-TREND® technology in China

The National Intellectual Property Administration of the P.R.C. (CNIPA) has awarded Cerenion its third patent on C-Trend® technology in China. For the C-Trend EEG analysis software, this patent is the eleventh globally.
The patent gives a strong protection to the C-Trend Index algorithm, a core component of Cerenion's C-Trend technology. This algorithm processes EEG signals, transforming them into a single numerical value, the C-Trend Index. This index provides a concise measure of a patient's EEG slow wave activity, a fundamental aspect of a healthy brain, typically observed during periods of sedation and deep sleep.
Cerenion's C-Trend technology has successfully secured several patents in the United States, the European Union, Japan, and China, and multiple applications for intellectual property rights have been initiated on a global scale.
Visit us
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Contact us
Call us: +358 50 447 4909
E-mail us:
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2023 Cerenion Oy